Corbus Pharmaceuticals Holdings Inc (CRBP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 RIVER RIDGE DRIVE NORWOOD, MA 02062

Corbus Pharmaceuticals Holdings, Inc. focuses on the development and commercialization of new therapies for inflammatory-fibrotic diseases. The Company treats rare, life-threatening diseases with its products. Corbus Pharmaceuticals Holdings engages in planning, research, development and recruiting.

Data based on most recent fiscal year report
Market Cap312.759 Million Shares Outstanding54.87 Million Avg Volume1.293 Million
1-Yr BETA vs S&P TR1.572 Current Ratio7.99 Quick Ratio7.99
View SEC Filings from CRBP instead.
Q2 2019 All Institutions Hedge Funds 1
To trade CRBP now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 102 8 (0.83%)
Aggregate 13F shares on 06/30/2019: 32.336 Million 2.549 Million
Aggregate 13F shares on 03/31/2019: 23.63 Million 2.28 Million
Percent change: 36.84% 11.80%
Funds creating new positions: 20
Funds Adding to an existing position: 29 2
Funds closing out their position: 13 2
Funds reducing their position: 28 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRBP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

20.8 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MILLIAN CRAIG STUART CHIEF COMMERCIAL OFFICER

  • Officer
9,000 2019-08-15 6

COHEN YUVAL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
65,360 2019-08-12 4

WHITE BARBARA CHIEF MEDICAL OFFICER

  • Officer
187,187 2019-08-12 4

DISCORDIA ROBERT PAUL CHIEF OPERATING OFFICER

  • Officer
30,150 2019-08-12 3

HOCHMAN DAVID P

  • Director
  • CHAIRMAN OF THE BOARD
3,532,610 2019-07-01 2

CATLIN AVERY W

  • Director
0 2019-06-24 1

PANAYIOTOPOULOS PARIS

  • Director
13,881 2019-05-30 1

HOLMER ALAN F

  • Director
0 2019-05-22 1

JENKINS JOHN KENNETH

  • Director
0 2019-05-22 2

JACQUES RACHELLE SUZANNE

  • Director
0 2019-05-22 3

MORAN SEAN F. CHIEF FINANCIAL OFFICER

  • Officer
349,610 2019-05-14 3

KNOLL CAPITAL MANAGEMENT, LP

  • 10% Owner
2,910,319 2019-04-09 0

TEPPER MARK PRESIDENT AND CSO

  • Officer
0 2019-01-18 2

GUPTA RENU

  • Director
0 2017-05-25 0

BURSTEIN SUMNER

  • FORMER 10% HOLDER
No longer subject to file 2015-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MILLIAN CRAIG STUART - Officer CHIEF COMMERCIAL OFFICER

2019-08-15 P 1,500 $5.48 a 9,000 9,000.00 direct

DISCORDIA ROBERT PAUL - Officer CHIEF OPERATING OFFICER

2019-08-12 P 15,000 $5.86 a 30,150 30,150.00 direct

WHITE BARBARA - Officer CHIEF MEDICAL OFFICER

2019-08-12 P 1,639 $6.10 a 187,187 187,187.00 direct

COHEN YUVAL - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-12 P 1,175 $6.06 a 65,360 65,360.00 direct

MILLIAN CRAIG STUART - Officer CHIEF COMMERCIAL OFFICER

2019-08-12 P 1,500 $6.00 a 7,500 7,500.00 direct

DISCORDIA ROBERT PAUL - Officer CHIEF OPERATING OFFICER

2019-08-06 A 100,000 a 100,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments